Results 141 to 150 of about 8,275 (244)

The Interacting Multiple Model Filter and Smoother on Boxplus-Manifolds. [PDF]

Sensors (Basel), 2021
Koller TL, Frese U.
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

SVM action recognition model based on skeletal key point analysis with posture sensors to help sports training. [PDF]

BMC Sports Sci Med Rehabil
Cao Y, Li T.
europepmc   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

Molecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Exploring synergistic patterns in bimanual distal limb movements through low dimensional representations. [PDF]

Sci Rep
Shenoy P, Varadhan SKM.
europepmc   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

In Flight Performance of the MAGIC Magnetoresistive Magnetometer on the RadCube CubeSat. [PDF]

Space Sci Rev
Eastwood JP, Brown P, Oddy T, Archer MO, Baughen R, Belo Ferreira I, Cobo Torres C, Cupido E, Eshbaugh H, Palla C, Vitkova A, Waters CL, Whiteside B, Zabori B, Hirn A, Nolbert D, Milánkovich D, Kovács ZG, Santin G, Walker R.   +19 more
europepmc   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Towards a zero-shot low-latency navigation for open surgery augmented reality applications. [PDF]

Int J Comput Assist Radiol Surg
Schwimmbeck M, Khajarian S, Auer C, Wittenberg T, Remmele S.   +4 more
europepmc   +1 more source

Self-Calibrating Magnetometer-Free Inertial Motion Tracking of 2-DoF Joints. [PDF]

Sensors (Basel), 2022
Laidig D, Weygers I, Seel T.
europepmc   +1 more source